Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

United States Medical Device Outsourcing Market Report 2021 Featuring Integer, Avail Medical Products, Active Implants, Omnica, Teleflex, Kinetic Climax, & Cantel Medical


DUBLIN, Nov. 30, 2021 /PRNewswire/ -- The "U.S. Medical Device Outsourcing Market Size, Share & Trends Analysis & Forecasts 2021" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The U.S. medical device outsourcing market size is expected to reach USD 46.2 billion by 2028 and is expected to expand at a CAGR of 10.3% from 2021 to 2028

The growing geriatric population, rising surgical procedures, and increasing demand for cost curbing tools are some key growth drivers for the U.S. market.

The medical device industry has become competitive and categories such as coronary stents, orthopedic devices, and wound care are moving towards maturity. As high-impact scientific innovation in the above categories is difficult to identify, smaller companies are gaining market share by offering low prices and introducing innovative business models.

Due to the convergence of mounting challenges and changing market dynamics, many medical device manufacturers have opted for outsourcing business models to reduce cost, manage business risks, and improve service delivery. All the aforementioned facts are hence expected to propel the market growth over the forecast period.

The development of medical devices and supplies required in assisting COVID patients and medical professionals is increasing. The government authorities have escalated funds for the research & development of essential devices, thus increasing the demand in the U.S. market.

Major companies have solely relied on contract manufacturers to ramp up the production of COVID-19-related medical components, such as test kits, ventilators, and respirators. The major reasons for outsourcing amid the COVID crisis include a streamlined supply chain, costing efficiencies, and logistical alignment.

U.S. Medical Device Outsourcing Market Report Highlights

Key Topics Covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Market Variables, Trends & Scope
3.1 Market Dynamic
3.1.1 Market Driver Analysis
3.1.1.1 Changing Regulatory Landscape
3.1.1.2 Rising Demand for the Advanced Products
3.1.1.3 Implementation of the International Standards by the Contract Manufacturers
3.1.1.4 Rising Price Competition and the Requirement to Reduce Cost
3.1.1.5 Increasing Complexity with Respect to Product Design and Engineering
3.1.2 Market Restraint Analysis
3.1.2.1 Compliance Issues While Outsourcing
3.1.2.2 Contractual Obligation
3.1.3 Industry Challenges
3.1.3.1 Managing Relationships
3.1.4 Impact of Covid-19 Pandemic
3.1.4.1 Impact on the U.S. medical device outsourcing market
3.1.4.2 Impact on Supply Chain
3.1.4.3 After effect of the pandemic
3.1.4.4 Impact Analysis
3.2 U.S. Medical Devices Outsourcing Market Analysis Tools
3.2.1 Industry Analysis - Porter's
3.2.2 PESTEL Analysis

Chapter 4 U.S. Medical Device Outsourcing Market: Segment Analysis, By Service, 2016 - 2028 (USD Million)
4.1 Definitions and Scope
4.2 Service Market Share Analysis
4.3 Segment Dashboard
4.4 Quality Assurance Services
4.4.1 Quality Assurance Services Market Estimates and Forecast, 2016 - 2028
4.5 Regulatory Consulting Services
4.5.1 Regulatory Consulting Services Market, 2016 - 2028 (USD Million)
4.5.2 Clinical Trial Application and Product Registration
4.5.3 Regulatory Writing and Publishing
4.5.4 Legal Representation
4.6 Product Design and Development
4.6.1 Product Design and Development Services Market, 2016 - 2028 (USD Million)
4.6.2 Designing and Engineering
4.6.3 Machining
4.6.4 Molding
4.6.5 Packaging
4.7 Product Testing And Sterilization
4.8 Product Implementation
4.9 Product Upgrade
4.10 Product Maintenance
4.11 Contract Manufacturing
4.11.1 Contract Manufacturing Market, 2016 - 2028 (USD Million)
4.11.2 Accessories Manufacturing
4.11.3 Assembly Manufacturing
4.11.4 Component Manufacturing
4.11.5 Device Manufacturing

Chapter 5 U.S. Medical Device Outsourcing Market: Segment Analysis, By Application, 2016 - 2028 (USD Million)
5.1 Definitions and Scope
5.2 Application Market Share Analysis
5.3 Segment Dashboard
5.4 Class I
5.5 Class II
5.6 Class III

Chapter 6 Competitive Landscape
6.1 Key Company Profiles
6.1.1 Company overview
6.1.2 Financial performance
6.1.3 Product benchmarking
6.1.4 Strategic initiatives

For more information about this report visit https://www.researchandmarkets.com/r/7xpzft

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 05:05
BeiGene , a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide, today announced that the Center for Drug Evaluation (CDE) of the China...

at 05:05
The "Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2021" report has been added to ResearchAndMarkets.com's offering. The Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2021 report is your one-stop source for...

at 05:00
ImmPACT Bio USA, Inc. ("ImmPACT Bio"), a clinical-stage company developing transformative logic-gate based chimeric antigen receptor (CAR) T-cell therapies for treating cancer, today announced it has closed $111 million in Series B financing, led by...

at 04:30
The neurostimulation devices market size is anticipated to record a valuation of USD 13.6 billion by 2027, according to the...

at 04:30
Amgen today announced that LUMAKRAS® (sotorasib) has been approved in Japan for the treatment of KRAS G12C-mutated positive, unresectable, advanced and/or recurrent non-small cell lung cancer (NSCLC) that has progressed after systemic anticancer...

at 04:00
The creators behind isoNeck Pillow are isoLife and they are returning to the crowdfunding scene for the second time with their newest innovation. After raising $281,402 with isoSpine, their first crowdfunded back-massage product in 2020, they were...



News published on 30 november 2021 at 16:30 and distributed by: